SharePost Content Read More Yahoo Finance #finance Post navigation Arm Holdings (ARM) Gets BofA Backing, 37% PT Upgrade, Climbs 11% Enliven Therapeutics (ELVN) Soars on Stellar Leukemia Drug Trial